Point-Of-Care Ultrasound-Driven vs Standard Diagnostic Pathway in Emergency Department Patients With Dyspnea
POCUS PATHWAY
Effect of a Point-Of-Care Ultrasound-Driven vs Standard Diagnostic Pathway on 24-Hour Hospital Stay in Emergency Department Patients With Dyspnea - a Randomized Controlled Trial
1 other identifier
interventional
674
1 country
9
Brief Summary
The POCUS PATHWAY-trial is a multi-center, randomized, investigator-initiated, open labelled, pragmatic, controlled trial of a point-of-care ultrasound-driven diagnostic pathway vs standard diagnostic pathway in dyspneic emergency department patients. The primary outcome will be 24-hour hospital stay and 642 patients will be included. Key secondary outcomes include overall hospital length of stay, image resources, and 72-hour revisits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2022
CompletedFirst Posted
Study publicly available on registry
January 9, 2023
CompletedStudy Start
First participant enrolled
January 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2024
CompletedOctober 1, 2024
September 1, 2024
1.6 years
December 16, 2022
September 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
24-hour hospital stay
Proportion of patients with a hospital lenght-of-stay of less than 24 hours.
From date of hospital admission until the date of first documented hospital discharge, assessed up to 24 hours.
Secondary Outcomes (3)
Hospital length-of-stay
From date of hospital admission until the date of first documented hospital discharge, assessed up to 3 months.
Image resources
From date of hospital admission until the date of first documented hospital discharge, assessed up to 3 months.
Number of participants with the composite outcome of 72-hour revisits and overall mortality
From date of hospital admission until 72 hours after the date of first documented hospital discharge, assessed up to 3 months.
Study Arms (2)
Point-of-care ultrasound-driven diagnostic pathway
EXPERIMENTALThe intervention is focused lung and cardiac ultrasound performed as an extension to physical examinations plus diagnostic decision recommendations based on those test results (a point-of-care ultrasound-driven diagnostic pathway). Final decision on next-line imaging and further diagnostic testing should incorporate history and other physical examinations and will remain upon the treating physicians' discretion.
Standard diagnostic pathway
NO INTERVENTIONStandard diagnostic pathway will include, but not be limited to, blood samples, blood gases, electrocardiogram, and chest x-ray. Focused lung and cardiac ultrasound cannot be performed while the patients stay in the emergency department.
Interventions
Focused lung ultrasound will include 8 zones (anterior and lateral) and evaluate pneumothorax, interstitial syndrome, lung consolidation, and pleural effusion. Focused cardiac ultrasound will include four views (subxiphoid four-chamber view, parasternal long-axis view, parasternal short-axis view, and apical four-chamber view) and evaluate pericardial fluid, right ventricle dilation, and left ventricular systolic contractility.
Eligibility Criteria
You may qualify if:
- Emergency department contact
- Age ≥ 18 years
- Chief complaint is Dyspnea
- Including physician present
You may not qualify if:
- Fulfilling of criteria for coded rapid-response teams (i.e., trauma, surgical or medical emergencies).
- Prior focused lung or focused cardiac ultrasound in the current emergency department stay
- Prior enrollment in the trial
- Unable to consent
- Non Danish-speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Herlev Hospital
Herlev, Capital Denmark Region, 2730, Denmark
Aarhus University Hospital
Aarhus, Central Jutland, 8200, Denmark
Gødstrup Regional Hospital
Gødstrup, Central Jutland, 7400, Denmark
Horsens Regional Hospital
Horsens, Central Jutland, 8700, Denmark
Viborg Regional Hospital
Viborg, Central Jutland, 8800, Denmark
University Hospital of Southern Denmark, Esbjerg
Esbjerg, Region Syddanmark, 6700, Denmark
Odense University Hospital
Odense, Region Syddanmark, 5000, Denmark
Zealand University Hospital, Køge
Køge, Zealand Denmark Region, 4600, Denmark
Slagelse Hospital
Slagelse, Zealand Denmark Region, 4200, Denmark
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stig H Ovesen
Aarhus University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Principal Investigator
Study Record Dates
First Submitted
December 16, 2022
First Posted
January 9, 2023
Study Start
January 25, 2023
Primary Completion
August 24, 2024
Study Completion
September 25, 2024
Last Updated
October 1, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- There will be no predetermined end date for the data sharing.
- Access Criteria
- Data will be available for any research purpose to all interested parties who have approval from an independent review committee and who have a methodological sound proposal as determined by the steering committee of the current trial. Only the methodological qualities and not the purpose or objective of the proposal will be considered. Interested parties will be able to request the data by contacting the principal investigator.
Six months after the publication of the last results, all de-identified individual patient data will be made available for data sharing.